A Randomized, Blinded, Single Center and Parallel Controlled Trial for Evaluating the Immunogenicity and Safety of Sequential Inoculation of Type I & III Live Attenuated OPV (Human Diploid Cells) and IPV Vaccine for Infants Aged 2 Months

Trial Profile

A Randomized, Blinded, Single Center and Parallel Controlled Trial for Evaluating the Immunogenicity and Safety of Sequential Inoculation of Type I & III Live Attenuated OPV (Human Diploid Cells) and IPV Vaccine for Infants Aged 2 Months

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Poliovirus vaccine live oral (Primary)
  • Indications Poliomyelitis
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Beijing Tiantan Biological Products Company
  • Most Recent Events

    • 26 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top